Engineers Gate Manager’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
110,807
+21,023
| +23% | +$311K | 0.02% | 844 |
|
|
2025
Q1 | $1.61M | Buy |
+89,784
| New | +$1.61M | 0.03% | 801 |
|
|
2024
Q4 | – | Sell |
-62,245
| Closed | -$871K | – | 2585 |
|
|
2024
Q3 | $871K | Buy |
62,245
+20,485
| +49% | +$287K | 0.02% | 1087 |
|
|
2024
Q2 | $343K | Buy |
+41,760
| New | +$343K | 0.01% | 1392 |
|
|
2023
Q4 | – | Sell |
-108,375
| Closed | -$969K | – | 2274 |
|
|
2023
Q3 | $969K | Buy |
108,375
+48,485
| +81% | +$433K | 0.04% | 724 |
|
|
2023
Q2 | $920K | Buy |
59,890
+36,618
| +157% | +$562K | 0.03% | 738 |
|
|
2023
Q1 | $523K | Buy |
+23,272
| New | +$523K | 0.02% | 955 |
|
|
2022
Q4 | – | Sell |
-17,762
| Closed | -$438K | – | 2047 |
|
|
2022
Q3 | $438K | Buy |
+17,762
| New | +$438K | 0.03% | 898 |
|
|
2022
Q2 | – | Sell |
-16,331
| Closed | -$421K | – | 2272 |
|
|
2022
Q1 | $421K | Sell |
16,331
-7,469
| -31% | -$193K | 0.02% | 1163 |
|
|
2021
Q4 | $739K | Buy |
23,800
+7,646
| +47% | +$237K | 0.03% | 784 |
|
|
2021
Q3 | $392K | Buy |
+16,154
| New | +$392K | 0.02% | 1034 |
|
|
2020
Q4 | – | Sell |
-13,420
| Closed | -$248K | – | 1994 |
|
|
2020
Q3 | $248K | Buy |
+13,420
| New | +$248K | 0.01% | 1341 |
|
|
2020
Q2 | – | Sell |
-10,860
| Closed | -$158K | – | 1980 |
|
|
2020
Q1 | $158K | Sell |
10,860
-1,591
| -13% | -$23.1K | 0.01% | 1324 |
|
|
2019
Q4 | $177K | Buy |
+12,451
| New | +$177K | 0.01% | 1493 |
|